Niagen Bioscience, Inc.

Niagen Bioscience, Inc., formerly known as ChromaDex Corporation, is a bioscience company focused on developing healthy aging products. Its operations are structured into Consumer products, Ingredients, and Pharmaceutical segments. The company commercializes the NAD+ precursor nicotinamide riboside as its flagship ingredient under the NIAGEN brand name. It distributes TRU NIAGEN products directly to consumers through its proprietary e-commerce platform TRUNIAGEN.com, Amazon, internet marketplaces, specialty retailers, and authorized healthcare practitioner resellers. Additionally, it provides finished dietary supplement products containing its proprietary ingredients to consumers and distributors. The company also develops and commercializes proprietary ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen, supplying these as raw materials to manufacturers of consumer products.

Niagen Bioscience, Inc. is listed on the Nasdaq Capital Market (NasdaqCM) under the ticker symbol NAGE. Its shares are traded in US dollars (USD). The company is headquartered in Los Angeles, California, United States, and its primary operations are based in the US market.

Niagen Bioscience operates in the Healthcare sector, specifically within the Biotechnology industry. As a biotechnology company, it focuses on developing and commercializing products related to healthy aging, particularly centered around NAD+ (nicotinamide adenine dinucleotide), an essential coenzyme that regulates cellular metabolism. The company's work involves both consumer dietary supplements and pharmaceutical-grade ingredients.

Niagen Bioscience is headquartered in Los Angeles, California, United States. The company serves consumers primarily in the United States and globally through its e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces. It also distributes through specialty retailers and authorized healthcare practitioner resellers. While its main market is the US, its products are available internationally via online channels.

Niagen Bioscience generates revenue through multiple streams. It sells finished dietary supplement products, such as TRU NIAGEN, directly to consumers via its proprietary e-commerce platform, Amazon, and other online marketplaces, as well as through specialty retailers and healthcare practitioner resellers. Additionally, the company supplies its proprietary ingredients, including food-grade, Niagen, and pharmaceutical-grade Niagen, as raw materials to manufacturers of consumer products. The Ingredients segment focuses on selling these ingredients to other companies, while the Pharmaceutical segment develops pharmaceutical-grade Niagen for potential therapeutic applications. The company also earns from licensing its proprietary technologies.